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OVEREXPRESSION OF APOBEC3B ENHANCES INVASIVENESS OF 
HEPATOCELLULAR CARCINOMA 
This study aims at revealing the roles of APOBEC3B (A3B) in human hepatocellular carcinoma 
(HCC). HCC is a leading cancer worldwide and specifically prevalent in Southeast Asia, due to 
prevalent hepatitis B virus (HBV) infection. Recent evidence has implicated A3B, a DNA 
deaminase, as a source of mutations in breast, cervical and bladder cancers. For example, A3B 
was found upregulated and active in the majority of breast cancer cell lines, and its upregulation 
in tumors correlated with increased C-to-T transition and overall base substitution mutations. 
A3B is one of seven APOBEC3 deaminases, which is responsible for providing innate immunity 
to a large number of DNA-based viruses. All these enzymes exhibit DNA deaminase activity. 
Transgenic expression of APOBEC1 and AID can induce tumor formation in mice which 
suggests links between mutagenesis, immunity and viral infection in cancer development. 
However, their roles in HCC remains largely undiscovered. 
We sequenced 16 pairs of HCC and corresponding non-tumorous livers using whole 
transcriptome sequencing (RNA-seq) and exome sequencing. We found that A3B expression was 
significantly overexpressed in HCC as compared to the corresponding non-tumorous liver for 13 
of the 16 samples (81.3%) (p < 0.001). Moreover, the frequency of C-to-U and G-to-A mutations 
was associated with the metastasis status and significant association was detected at RNA level (p 
= 0.015) while a similar trend was also observed at the DNA level (p = 0.059 for C>T plus G>A 
events). 
To validate the expression in a larger cohort of human HCCs, we performed real-time 
quantitative PCR (qPCR) on 55 pairs of human HCCs. We consistently observed a frequent 
(70.9%) and significant overexpression (p<0.001) of A3B in HCCs. The result was also 
confirmed at the protein level by immunohistochemistry and western blotting. Clinical-
pathological analysis revealed that A3B overexpression in HCCs was significantly associated 
with more aggressive tumor behavior including the presence of tumor microsatellite formation 
(p=0.009), venous invasion (p=0.021), direct invasion into the adjacent liver tissue (p=0.033) and 
more advanced tumor stages (p=0.017). In addition, overexpression of A3B in HCCs positively 
correlated with the presence of HBX truncation (P=0.017). We also examined the A3B 
expression in a 
panel of HCC cell lines and found that the A3B mRNA levels were higher in the HCC cell lines 
with higher metastatic potential. In vitro cell migration and invasion assays also showed that the 
HCC cells which had higher expression levels of A3B had higher migratory and invasive abilities. 
In conclusion, we demonstrated that A3B was overexpressed in HCC and its overexpression was 
associated with more aggressive tumor behavior. A3B overexpression might enhance the 
metastatic potential of HCC cells. 
